Kevin K. Chung, MD Profile picture
Apr 22, 2021 18 tweets 7 min read Read on X
Looking forward to welcoming Dr. Kari Nadeau to our next #USUMEDSeminar!

Feel free to Join us as always.

ZOOM Webinar: usuhs.zoom.us/j/92051022987

@USUhealthsci
@pwhickey
8% of children have a food allergy. #USUMEDSeminar
Which allergies occur together? 👇🏻

#USUMEDSeminar
Many factors contribute to #foodallergy.

It's not your fault (parents)!

#USUMEDSeminar
Avoidance in infants may result in an increase food allergy.

#USUMEDSeminar
Introduce foods early!

#USUMEDSeminar
There is a decay in tolerance after immunotherapy....

#USUMEDSeminar
The recording can be found here. 👇🏻👇🏻👇🏻
#USUMEDSeminar

drive.google.com/file/d/1GQAd5F…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Kevin K. Chung, MD

Kevin K. Chung, MD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @chungk1031

Feb 10, 2023
Been a while since I’ve done one of these.

A recent personal health related saga motivated me to put this one together. 👇

A 🧵

1/
First off, I am now fully recovered.

Thankful to the fantastic clinical teams @WRBethesda for the excellent and timely care provided. 🙏

2/
3 months ago, I began having post-prandial epigastric abdominal pain lasting 30-90 mins would resolve spontaneously…until one night, it just didn’t.

Pain 10/10. Could not sit still, constant with intermittently colicky. Went to the nearest ED.

3/
Read 18 tweets
Apr 24, 2021
A Multicenter Evaluation of Blood Purification with Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19: A Preliminary Report

medrxiv.org/content/10.110…
After adjusting for covariates, treatment with Seraph 100 decreased the Odds of death [OR 0.27, 95% CI 0.09-0.79, p=0.016].

#COVID19
Read 10 tweets
Dec 23, 2020
Dealing with dying patients.

#MedTwitter

A 🧵
I was prepping for a panel discussion with medical students on death and dying. Had to get some thoughts together based on my experience as a military intensivist so I thought I would share.
I’ve experienced my share of death. Of course the typical “taking terminal patients through the dying process” kind of stuff that every internist and intensivist deals with…
Read 13 tweets
May 22, 2020
How to get #verified.

A thread/
I am not an expert by any means.

But it took me 4 tries.

Each time I adjusted something that I think got me closer.

I thought I would share a few insights about how I think I got #verified so you can also.

2/
Why?

The power of this platform is undeniable.

Now more than ever, the voices of our collective expert medical community needs amplification.

Too many out there remain #notverified who should be.

⬆️ @verified science/medical experts = defeat misinformation
Read 9 tweets
May 12, 2020
I am giving a talk on "SARS-CoV-2 testing and Immunity" this week. Thought it would make a good #Tweetorial.

Thread/
First testing.

You can categorize testing as follows:

✅Pathogen based (test for presence of virus)

✅Host based (test for patient's response)
There have been a LOT of Emergency Use Authorizations granted by the FDA. For a variety of tests.
Read 18 tweets
May 2, 2020
I just saw this thread by @MarkHoofnagle and feel compelled to respond to clarify some things.

Disclaimers: I am not an ID expert. I am a Medical Intensivist in the Military. These are not the official views of the DoD. Just my personal opinions. No financial COIs.

1/
I have participated only as a site-AI but I have participated in investigator meetings since the inception of this trial so I have *some* inside knowledge.

2/
First off, this trial was conceived and protocol approved before our very first US case back in February. It is funded by NIAID. Not Gilead. Remdesivir was chosen because of its potential. Not financially motivated.

Full info here. 👇

clinicaltrials.gov/ct2/show/NCT04…
Read 19 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(